Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Mai-Britt_Zocca
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:country |
gptkb:Denmark
|
| gptkbp:developedBy |
novel immune-modulating cancer therapies
|
| gptkbp:focusesOn |
immunotherapy
|
| gptkbp:foundedYear |
2015
|
| gptkbp:founder |
gptkb:Mai-Britt_Zocca
|
| gptkbp:headquartersLocation |
gptkb:Copenhagen,_Denmark
|
| https://www.w3.org/2000/01/rdf-schema#label |
IO Biotech
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:leadProductCandidate |
IO102-IO103
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
IOBT
|
| gptkbp:website |
https://iobiotech.com/
|
| gptkbp:bfsParent |
gptkb:Mai-Britt_Zocca
|
| gptkbp:bfsLayer |
8
|